Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:20 PM
Ignite Modification Date:
2025-12-24 @ 1:20 PM
NCT ID:
NCT06627595
Eligibility Criteria:
Inclusion Criteria:
* age 18 years or above
* ECOG performance status inferior or equal to 3
* patient with a melanoma confirmed histologically/pathologically
* indication for initiating treatment with anti-PD1 immunotherapy or anti-PD1 + anti-CTLA4
Exclusion Criteria:
* patient unable to read and/or write
* inability to follow up with the patient during the study period
* refusal to participate after a reflection period
* medical contraindication to initiating immunotherapy (active autoimmune disease requiring systemic treatment in the past 2 years, active infection, etc.)
* not affiliated with a social security system
* patient under legal protection, guardianship, or curatorship
* person participating in another study that includes an ongoing exclusion period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06627595
Study Brief:
Protocol Section:
NCT06627595